Corpus Intelligence IC Memo — GARFIELD MEMORIAL HOSPITAL 2026-04-26 05:27 UTC
IC Memo — GARFIELD MEMORIAL HOSPITAL
Investment Committee Memorandum | UT | 15 beds | Grade C | EBITDA uplift $1.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

GARFIELD MEMORIAL HOSPITAL

CCN 461333 | GARFIELD, UT | 15 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

GARFIELD MEMORIAL HOSPITAL is a 15-bed rural/critical access in GARFIELD, UT with $14.3M in net patient revenue and a -1.4% operating margin. The hospital serves a payer mix of 61.9% Medicare, 4.6% Medicaid, and 33.6% commercial.

Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.4% to 5.9% (+737bps).

Net Revenue HCRIS$14.3M
Current EBITDA COMPUTED$-206K
Operating Margin COMPUTED-1.4%
Occupancy HCRIS27.1%
Revenue / Bed COMPUTED$955K
Net-to-Gross HCRIS59.4%
Distress Probability ML58.3%

2. Market Context & Competitive Position

59
UT Hospitals
8.0%
State Median Margin
18
Comparable Hospitals

UT has 59 Medicare-certified hospitals with a median operating margin of 8.0%. The target's margin of -1.4% places it below the state median. Among 18 size-comparable peers (8-30 beds), the median margin is -0.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-30), prioritizing same-state peers. 18 hospitals in the comp set.

HospitalStateBedsRevenueMargin
GARFIELD MEMORIAL HOSPITAL (Target)UT15$14.3M-1.4%
GUNNISON VALLEY HOSPITALUT25$130.4M-6.4%
SPANISH FORK HOSPITALUT16$65.3M0.5%
CENTRAL VALLEY MEDICAL CENTERUT25$60.7M4.3%
SEVIER VALLEY HOSPITALUT24$58.2M14.5%
HEBER VALLEY HOSPITALUT19$55.8M8.4%
MOAB REGIONAL HOSPITALUT17$44.2M-3.4%
CACHE VALLEY HOSPITALUT28$34.7M-12.4%
OREM COMMUNITY HOSPITALUT24$34.2M4.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (737bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$301K+210bp18mo
Cost to Collect4.5%2.5%$287K+200bp12mo
Denial Rate Reduction12.0%6.5%$284K+198bp12mo
A/R Days Reduction5200.0%3800.0%$174K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$301K
Cost to Collect
$287K
Denial Rate Reduction
$284K
A/R Days Reduction
$174K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.1M
Current EBITDA$-206K
+ RCM Uplift+$1.1M
Pro Forma EBITDA$849K
Current Margin-1.4%
Pro Forma Margin5.9%
WC Released (1x)$550K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-318K$9.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-318K$10.0M0.00x-100.0%
Bull Case9.0x11.0x$-286K$13.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-286K$14.5M0.00x-100.0%
Bear Case11.0x10.0x$-349K$4.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-349K$4.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 61.9% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 27.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 58.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 18 hospitals with 8-30 beds
  • Same-state prioritization (n=19)
  • Comp margins: P25=-11.3% / P50=-0.9% / P75=5.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.